Allergy and Immunology Billing Experts

Allergy and Immunology Medical Billing Services

Allergy and immunology billing involves a distinctive combination of testing, immunotherapy, and E/M services.

Get Your Free Assessment Explore the Guide
Allergy and Immunology Medical Billing Services
96%

First-Pass Clean Claim Rate

$14K

Avg. Monthly Revenue Recovered

18 Days

Average Days to Payment

3.2%

Client Denial Rate

Overview

Navigating the Complex World of Allergy Testing and Immunotherapy Billing

Allergy and immunology billing involves a distinctive combination of testing, immunotherapy, and E/M services. Percutaneous allergy testing (95004) and intradermal testing (95024, 95027) are billed per test, and the number of tests performed must align with clinical indications. Payers frequently impose limits on the number of allergens tested per session, denying claims that exceed their threshold.

Immunotherapy administration codes (95115-95170) require careful tracking of injection schedules, dose preparation, and observation periods. Multi-dose vial preparation (95165) is billed separately from injection administration, and many practices lose revenue by failing to capture both components.

Navigating the Complex World of Allergy Testing and Immunotherapy Billing
Challenges

Common Allergy and Immunology billing Challenges We Solve

Every Allergy and Immunology billing team deals with payer delays, coding nuance, and collection leakage.

Multi-Test Encounter Coding

Allergy testing sessions often involve 50 or more individual percutaneous tests (95004) followed by intradermal testing (95024). Each payer has different rules on maximum billable tests per session, and incorrect bundling can cost practices thousands in denied claims per month.

Immunotherapy Authorization Tracking

Immunotherapy protocols span months or years, requiring ongoing prior authorizations. Payers frequently require updated documentation of treatment efficacy, and missed renewal deadlines result in coverage gaps that leave patients responsible for injection costs.

Biologic Medication Billing

High-cost biologics like omalizumab (J2357) and dupilumab (J0593) require buy-and-bill processes with specific documentation of medical necessity, step therapy compliance, and ongoing outcome reporting to maintain payer approval.

Component vs. Panel Testing Rules

Payers differ on whether allergen-specific IgE tests should be billed as individual components (86003) or as panels (86005). Billing the wrong way triggers automatic denials, and appeal processes vary significantly across commercial carriers.

Services

Complete Allergy and Immunology billing Services

Support spans the full revenue cycle.

Allergy skin test coding (95004, 95017, 95018, 95024)

Immunotherapy injection billing (95115, 95117, 95120, 95125)

Biologic medication buy-and-bill management

Prior authorization for allergy testing panels

In-vitro allergen-specific IgE coding (86003, 86005)

Vial preparation and mixing charge capture (95165)

Coverage

Serving Allergy and Immunology billing Teams Nationwide

We support independent practices and growing provider organizations.

Independent physician groups

Multi-location practices

Private equity backed platforms

Hospital-owned outpatient groups

Guide

The Complete Guide to Allergy and Immunology billing

Allergy and Immunology Billing: Testing Panels, Immunotherapy, and Payer Rules

Allergy and immunology practices face unique billing complexity because revenue depends on high-volume testing sessions and long-term immunotherapy protocols. Accurate coding and an understanding of payer-specific limitations are critical to maintaining cash flow and avoiding recoupment demands.

Allergy Testing Codes and Session Limits

Percutaneous (scratch) testing is reported with 95004, billed per test. Intradermal testing uses 95024 for sequential and incremental testing. Most commercial payers allow 70 to 80 percutaneous tests per session, while Medicare caps reimbursement at approximately 80 tests per encounter. Exceeding these limits without documented medical justification triggers automatic denials. Each test must correspond to a clinically relevant allergen based on the patient’s history, geography, and symptom pattern. Blanket panel testing without individualized rationale is a common audit flag.

Allergen-specific IgE blood testing (86003) is an alternative when skin testing is contraindicated, such as for patients on antihistamines or with severe dermatologic conditions. Payers typically require documentation explaining why skin testing was not performed before approving in-vitro testing claims.

Immunotherapy Billing: Administration and Preparation

Immunotherapy billing splits into two distinct components. Antigen preparation is reported with 95165, billed per dose of each antigen included in the treatment vial. Injection administration uses 95115 for a single injection and 95117 for two or more injections. A common billing error is failing to separately report the preparation and administration components, which leaves significant revenue on the table.

Medicare and most commercial plans reimburse antigen preparation when performed by the treating provider’s office. If serum is prepared by an outside laboratory, the preparing entity bills 95165 and the administering office bills only the injection codes. Practices that prepare their own antigens should verify that their billing system captures both the preparation and administration charges for every immunotherapy visit.

Payer Considerations and Prior Authorization

Many plans require prior authorization for immunotherapy courses, typically in 12-month blocks. UnitedHealthcare and Aetna both require submission of skin test results and a treatment plan before approving the first injection series. Cigna may limit the number of antigens per vial to 10 without additional documentation. Practices should build authorization tracking into their workflow, since a lapsed authorization results in denied claims for every injection administered during the gap period. Proper use of diagnosis codes such as J30.1 (allergic rhinitis due to pollen) and J45.20 (mild intermittent asthma) strengthens medical necessity for both testing and treatment.

Common Questions

Frequently Asked Questions About Allergy and Immunology billing

Answers to the questions practice owners ask most often.

We code each percutaneous test using 95004 with the correct number of units, verify payer limits on tests per session, and apply appropriate modifiers when intradermal testing (95024) follows in the same encounter. Our team tracks payer-specific maximums to prevent denials before submission.

Most commercial payers reimburse immunotherapy injection claims (95115, 95117) within 14 to 21 days when submitted with proper documentation. We track each patient's authorization status and renewal dates to prevent coverage lapses that delay payment.

Yes. We manage the full prior authorization process for biologics including omalizumab and dupilumab, from initial submission with clinical documentation through appeals if the initial request is denied. Our approval rate for biologic authorizations exceeds 92%.

We audit every claim against payer-specific rules before submission, verify that testing documentation supports medical necessity, and ensure modifier usage aligns with each carrier's requirements. This pre-submission review reduces first-pass denial rates to under 4% for our allergy clients.

Yes, when medically appropriate and supported by documentation. We apply modifier 59 or XS to distinguish the testing service from the injection administration, following each payer's specific bundling rules to ensure both services are reimbursed.

We deliver monthly reports covering revenue by service type (testing, injections, biologics), denial rates by payer, authorization renewal schedules, and aging accounts receivable. You also receive quarterly trend analysis showing revenue per patient visit.

READY TO GET STARTED?

Start Billing Smarter for Allergy and Immunology billing

Get a revenue review and a clear action plan tailored to your practice.

Get Your Free Assessment

HIPAA Compliant · No Upfront Fees · No Long-Term Contracts